Skip to main content
Erschienen in: Pediatric Cardiology 2/2013

01.02.2013 | Case Report

Extreme Clinical Variability of Dilated Cardiomyopathy in Two Siblings With Alström Syndrome

verfasst von: Jamal Mahamid, Avraham Lorber, Yoseph Horovitz, Stavit A. Shalev, Gayle B. Collin, Jürgen K. Naggert, Jan D. Marshall, Ronen Spiegel

Erschienen in: Pediatric Cardiology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Alström syndrome (ALMS) is a rare autosomal recessive disorder caused by mutations in the ALMS1 gene. We report two brothers, 3 and 4 years of age and diagnosed with ALMS, who initially presented in infancy with severe dilated cardiomyopathy during febrile respiratory infection. The disease course in the two siblings was marked by significant intrafamilial variability. Although cardiomyopathy in the older sibling has mainly resolved thus allowing for the discontinuation of medical therapy, heart function in the younger sibling continues to deteriorate despite maximal drug support with furosemide, carvedilol, captopril, and aldospirone. Genetic analysis revealed homozygous mutations, c.8008C>T (R2670X), in ALMS1 resulting in premature protein truncation. This report further emphasizes the exceptional intrafamilial variability of ALMS, mainly during the natural course of cardiac disease.
Literatur
1.
Zurück zum Zitat Bond J, Flintoff K, Higgins J et al (2005) The importance of seeking ALMS1 mutations in infants with dilated cardiomyopathy. J Med Genet 42:e10PubMedCrossRef Bond J, Flintoff K, Higgins J et al (2005) The importance of seeking ALMS1 mutations in infants with dilated cardiomyopathy. J Med Genet 42:e10PubMedCrossRef
2.
Zurück zum Zitat Collin GB, Marshall JD, Ikeda A et al (2002) Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome. Nat Genet 31:74–78PubMed Collin GB, Marshall JD, Ikeda A et al (2002) Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome. Nat Genet 31:74–78PubMed
3.
Zurück zum Zitat Foerster SR, Canter CE, Cinar A et al (2010) Ventricular survival and survival are more favorable for myocarditis than for idiopathic dilated remodeling and cardiomyopathy in childhood: an outcomes study from the pediatric cardiomyopathy Registry. Circulation 3:689–697PubMed Foerster SR, Canter CE, Cinar A et al (2010) Ventricular survival and survival are more favorable for myocarditis than for idiopathic dilated remodeling and cardiomyopathy in childhood: an outcomes study from the pediatric cardiomyopathy Registry. Circulation 3:689–697PubMed
4.
Zurück zum Zitat Girard D, Petrovsky N (2011) Alström syndrome: insights into the pathogenesis of metabolic disorders. Nat Rev Endocrinol 7:77–88PubMedCrossRef Girard D, Petrovsky N (2011) Alström syndrome: insights into the pathogenesis of metabolic disorders. Nat Rev Endocrinol 7:77–88PubMedCrossRef
5.
Zurück zum Zitat Hearn T, Spalluto C, Phillips VJ et al (2005) Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes. Diabetes 54:1581–1587PubMedCrossRef Hearn T, Spalluto C, Phillips VJ et al (2005) Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes. Diabetes 54:1581–1587PubMedCrossRef
6.
Zurück zum Zitat Hoffman JD, Jacobson Z, Young TL et al (2005) Familial variable expression of dilated cardiomyopathy in Alström syndrome: a report of four sibs. Am J Med Genet A 135:96–98PubMed Hoffman JD, Jacobson Z, Young TL et al (2005) Familial variable expression of dilated cardiomyopathy in Alström syndrome: a report of four sibs. Am J Med Genet A 135:96–98PubMed
7.
Zurück zum Zitat Loudon MA, Bellenger NG, Carey CM et al (2009) Cardiac magnetic resonance imaging in Alström syndrome. Orphanet J Rare Dis 4:14PubMedCrossRef Loudon MA, Bellenger NG, Carey CM et al (2009) Cardiac magnetic resonance imaging in Alström syndrome. Orphanet J Rare Dis 4:14PubMedCrossRef
8.
Zurück zum Zitat Makaryus AN, Zubrow ME, Marshall JD et al (2007) Cardiac manifestations of Alström syndrome: echocardiographic findings. J Am Soc Echocardiogr 20:1359–1363PubMedCrossRef Makaryus AN, Zubrow ME, Marshall JD et al (2007) Cardiac manifestations of Alström syndrome: echocardiographic findings. J Am Soc Echocardiogr 20:1359–1363PubMedCrossRef
9.
Zurück zum Zitat Marshall JD, Bronson RT, Collin GB et al (2005) New Alström syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med 165:675–683PubMedCrossRef Marshall JD, Bronson RT, Collin GB et al (2005) New Alström syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med 165:675–683PubMedCrossRef
10.
11.
Zurück zum Zitat Minton JA, Owen KR, Ricketts CJ et al (2006) Syndromic obesity and diabetes: changes in body composition with age and mutation analysis of ALMS1 in 12 United Kingdom kindreds with Alstrom syndrome. J Clin Endocrinol Metab 91:3110–3116PubMedCrossRef Minton JA, Owen KR, Ricketts CJ et al (2006) Syndromic obesity and diabetes: changes in body composition with age and mutation analysis of ALMS1 in 12 United Kingdom kindreds with Alstrom syndrome. J Clin Endocrinol Metab 91:3110–3116PubMedCrossRef
12.
Zurück zum Zitat Pereiro I, Hoskins BE, Marshall JD et al (2011) Arrayed Primer Extension (APEX) technology simplifies mutation detection in Bardet Biedl and Alström Syndrome. Eur J Hum Genet 19:485–488PubMedCrossRef Pereiro I, Hoskins BE, Marshall JD et al (2011) Arrayed Primer Extension (APEX) technology simplifies mutation detection in Bardet Biedl and Alström Syndrome. Eur J Hum Genet 19:485–488PubMedCrossRef
13.
Zurück zum Zitat Towbin JA, Lowe AM, Colan SD et al (2006) Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296:1867–1876PubMedCrossRef Towbin JA, Lowe AM, Colan SD et al (2006) Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296:1867–1876PubMedCrossRef
14.
Zurück zum Zitat Zulato E, Favaretto F, Veronese C et al (2011) ALMS1-deficient fibroblasts over-express extra-cellular matrix components, display cell cycle delay and are resistant to apoptosis. PLoS One 6:e19081PubMedCrossRef Zulato E, Favaretto F, Veronese C et al (2011) ALMS1-deficient fibroblasts over-express extra-cellular matrix components, display cell cycle delay and are resistant to apoptosis. PLoS One 6:e19081PubMedCrossRef
Metadaten
Titel
Extreme Clinical Variability of Dilated Cardiomyopathy in Two Siblings With Alström Syndrome
verfasst von
Jamal Mahamid
Avraham Lorber
Yoseph Horovitz
Stavit A. Shalev
Gayle B. Collin
Jürgen K. Naggert
Jan D. Marshall
Ronen Spiegel
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
Pediatric Cardiology / Ausgabe 2/2013
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-012-0296-6

Weitere Artikel der Ausgabe 2/2013

Pediatric Cardiology 2/2013 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.